Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 298-190-5 | CAS number: 93778-52-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- (Q)SAR
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: publication, read-across
- Justification for type of information:
- On the basis of all evaluated data, the similarity of all category members of the ISOCARB is justified on basis of the physico-chemical properties, toxicological and ecotoxicological profiles. There is convincing evidence that these chemicals possess an overall common category profile. ISOCARB are aliphatic branched carboxylic acids and include substances with carbon chain lengths of C11 to C24. Their only functional group is the carboxyl group, which they share in common. All ISOCARB have a single branching at the C2 position, where the branches differ in chain length from methyl to decyl.
- Objective of study:
- toxicokinetics
- Qualifier:
- no guideline available
- GLP compliance:
- not specified
- Species:
- human
- Route of administration:
- oral: feed
- Vehicle:
- other: low-fat, natural foods
- Details on exposure:
- In a randomised, crossover, metabolic-ward study, 7 mildly hypercholesterolemic men were fed 3 natural food diets supplemented with behenate oil, palm oil, or high oleic acid sunflower oil. Mean serum lipid and lipoprotein concentrations and plasma triacylglycerol fatty acid comosition were determined druing final 4 d of each 3 week diet period.
- Duration and frequency of treatment / exposure:
- 3 weeks
- Remarks:
- Doses / Concentrations:
39.5 % (by weight) - No. of animals per sex per dose / concentration:
- 7 men
- Control animals:
- no
- Statistics:
- The mean values obtained for the 3 dietary periods were compared by performing a repeated-measures analysis of variance (ANOVA). When the ANOVA showed the results of diets to be different, paired t tests wtih Bonferroni correction for multiple comparisons were peformed. After Bonferroni correction, statistical significance was set at a P value of 0.0167 (<0.05/3).
- Details on absorption:
- Only approximately 30% of the dietary behenic acid was absorbed.
- Details on distribution in tissues:
- The appearance of behenic acid in plasma triacylglycerol fatty acids as a rough measure of absorption suggests that little if any behenic acid was absorbed and distributed intact to the fatty acid pool.
- Details on excretion:
- Behenic acid was recovered in the feaces
- Metabolites identified:
- yes
- Details on metabolites:
- Behenic acid may be hydrolyzed shortly after absorption into shorter-chain saturated fatty acids.
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results
- Executive summary:
Absorption: Only approximately 30% of the dietary behenic acid was absorbed.
Distribution: The appearance of behenic acid in plasma triacylglycerol fatty acids as a rough measure of absorption suggests that little if any behenic acid was absorbed and distributed intact to the fatty acid pool.
Metabolism: Behenic acid may be hydrolyzed shortly after absorption into shorter-chain saturated fatty acids.
Excretion: Behenic acid was recovered in the faeces.
Reference
Description of key information
Only approximately 30 % of the dietary Source substance 2 was absorbed.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 30
Additional information
No data on the test substance are available. The results from a study of the appearance of behenic acid in lymph samples from rats suggest that only 11 -24 % of dietary behenic acid is absorbed. The results from a study of the fecal content of behenic acid in hamsters suggests that only 19 -29 % of behenic acid is absorbed. In humans, who are known to have a greater capacity for absorbing stearic aicd than do animals, fecal recovery of behenic acid suggests that the mean absorption of behenic aicd is about 30 %. The finding that behenate oil feeding resulted in high concentrations of plasma triacylglycerol myristic, palmitic, and stearic acids suggests that behenic acid may be hydrolysed shortly after absorption into shorter-chain saturated fatty acids. These findings suggest that dietary behenic acid is extensively degraded to cholesterol-raising saturated fatty acids (Cater, N. B., Denke, M. A., Behenic acid is a cholesterol-raising saturated fatty acid in humans, Am J. Clin. Nutr., 2001; 73, p41 -44).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
